MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma
European Journal of Radiology Open · 2025-12 · 15 · 100711
DOI: 10.1016/j.ejro.2025.100711 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Radiology Open, 2025-12. Verfasst von Jing-Yi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Peking Union Medical College Hospital, Beijing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Pancreatic ductal adenocarcinoma (PDAC) has a high recurrence risk after R0 resection. This study aimed to evaluate the prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) pharmacokinetic parameters, including volume transfer constant (Ktrans), rate constant (kep), extracellular extravascular volume fraction (ve), and MRI-derived extracellular volume (ECV) fraction, for predicting early recurrence and survival after surgery.
Methods
In this retrospective cohort study, 61 patients (mean age 60.7 ± 9.7 years; 35 males) with histologically confirmed PDAC underwent preoperative 3 T MRI between January 2017 and May 2024, including DCE-MRI and dual-time-point T1 mapping. Two radiologists independently measured Ktrans, kep, ve, and ECV. Inter-observer agreement (ICC), associations with pathological features, and prognostic value for recurrence-free survival (RFS) and overall survival (OS) were analyzed using Cox regression, Kaplan-Meier analysis with log-rank tests, and time-dependent ROC curves.
Results
ECV demonstrated excellent reproducibility (ICC = 0.99) and independently predicted shorter RFS (HR = 1.020; 95 % CI: 1.003-1.038; p = 0.022). An optimal ECV cutoff of 31.99 % effectively stratified patients into high- and low-risk groups with significantly different median RFS (10.9 vs. 17.4 months, p = 0.012). However, other DCE-MRI parameters (Ktrans, kep, ve) showed poor reproducibility and lacked independent prognostic value for RFS or OS.
Conclusion
MRI-derived tumor ECV is a robust, reproducible biomarker for predicting early recurrence after R0 resection in PDAC patients, potentially assisting in preoperative risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Peking Union Medical College Hospital, Beijing, China.
- MR Research Collaboration, Siemens Healthineers, Beijing, China.
- Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany.
- Department of General Surgery, Peking Union Medical College Hospital, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, J. Y., Wang, Q., Lu, Y. T., Jiang, Y. L., Nichel, D., Grimm, R., Zhu, L., & Dai, M. H. (2025). MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma. European Journal of Radiology Open, 15, 100711. https://doi.org/10.1016/j.ejro.2025.100711
Vancouver
Liu JY, Wang Q, Lu YT, Jiang YL, Nichel D, Grimm R, et al. MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma. European Journal of Radiology Open. 2025;15:100711. doi:10.1016/j.ejro.2025.100711
BibTeX
@article{Liu2025,
author = {Liu, Jing-Yi and Wang, Qi and Lu, Yi-Tong and Jiang, Yue-Luan and Nichel, Dominik and Grimm, Robert and Zhu, Liang and Dai, Meng-Hua},
title = {MRI-derived extracellular volume fraction as a prognostic biomarker for early recurrence after R0 resection of pancreatic ductal adenocarcinoma},
journal = {European Journal of Radiology Open},
year = {2025},
volume = {15},
pages = {100711},
doi = {10.1016/j.ejro.2025.100711}
}
EUVIMED